Matches in SemOpenAlex for { <https://semopenalex.org/work/W3185221494> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W3185221494 endingPage "255" @default.
- W3185221494 startingPage "249" @default.
- W3185221494 abstract "Background and Objective: Borderline ovarian tumor (BOT) is a distinct but heterogeneous group of tumors defined by histopathology as atypical epithelial proliferation without stromal invasion. Women with BOT are usually younger than those with invasive carcinoma. This study aimed to evaluate the survival outcomes and prognostic factors of patients with BOT in a single institute in the northern region of Thailand. Methods: The medical records of patients with BOT who were treated at Chiang Mai University Hospital between January 1, 2008 and December 31, 2019 were reviewed. The survival outcomes were analyzed by the Kaplan-Meier method and prognostic factors were analyzed by univariate and multivariate approaches. Results: 168 patients with BOT were enrolled in the study. The median age was 48.8 years. At the median follow-up time of 25.4 months, 9 patients (5.3%) developed recurrence and 2 (1.1%) experienced progression to invasive carcinoma. The 5-year progression-free survival (PFS) and overall survival were 93.2% and 97.4%, respectively. By univariate analysis, advanced stage (p=0.02), tumor size smaller than 10 cm (p=0.03), conservative surgery (p=0.03), and bilateral tumors (p=0.07) were significantly associated with worse PFS. Hysterectomy was a protective factor for recurrence with the hazard ratio of 0.09 (95% CI, 0.01 – 0.77; p= 0.03). Cell types, pelvic lymphadenectomy, micro-invasion, and non-invasive peritoneal implant did not significantly affect PFS. By multivariate analysis, early stage (p=0.01), tumor size larger than 10 cm (p=0.04), and hysterectomy (p=0.03) were significantly associated with better survival. Conclusion: Patients with BOT had excellent survival outcomes. Tumor size of larger than 10 cm, early-stage disease, and hysterectomy were significant prognostic factors for better survival outcomes. Conservative surgery should be offered to patients who desire to preserve future fertility and long-term follow-up is needed to assure recurrence - free." @default.
- W3185221494 created "2021-08-02" @default.
- W3185221494 creator A5004095085 @default.
- W3185221494 creator A5025401062 @default.
- W3185221494 creator A5062329858 @default.
- W3185221494 creator A5065021475 @default.
- W3185221494 creator A5077116773 @default.
- W3185221494 creator A5080073089 @default.
- W3185221494 date "2021-07-23" @default.
- W3185221494 modified "2023-10-16" @default.
- W3185221494 title "Survival Outcomes and Prognostic Factors of Borderline Ovarian Tumors" @default.
- W3185221494 doi "https://doi.org/10.31557/apjcc.2021.6.3.249-255" @default.
- W3185221494 hasPublicationYear "2021" @default.
- W3185221494 type Work @default.
- W3185221494 sameAs 3185221494 @default.
- W3185221494 citedByCount "0" @default.
- W3185221494 crossrefType "journal-article" @default.
- W3185221494 hasAuthorship W3185221494A5004095085 @default.
- W3185221494 hasAuthorship W3185221494A5025401062 @default.
- W3185221494 hasAuthorship W3185221494A5062329858 @default.
- W3185221494 hasAuthorship W3185221494A5065021475 @default.
- W3185221494 hasAuthorship W3185221494A5077116773 @default.
- W3185221494 hasAuthorship W3185221494A5080073089 @default.
- W3185221494 hasBestOaLocation W31852214941 @default.
- W3185221494 hasConcept C121608353 @default.
- W3185221494 hasConcept C126322002 @default.
- W3185221494 hasConcept C142724271 @default.
- W3185221494 hasConcept C143998085 @default.
- W3185221494 hasConcept C144301174 @default.
- W3185221494 hasConcept C146357865 @default.
- W3185221494 hasConcept C151730666 @default.
- W3185221494 hasConcept C207103383 @default.
- W3185221494 hasConcept C2780824555 @default.
- W3185221494 hasConcept C38180746 @default.
- W3185221494 hasConcept C44249647 @default.
- W3185221494 hasConcept C544855455 @default.
- W3185221494 hasConcept C71924100 @default.
- W3185221494 hasConcept C86803240 @default.
- W3185221494 hasConceptScore W3185221494C121608353 @default.
- W3185221494 hasConceptScore W3185221494C126322002 @default.
- W3185221494 hasConceptScore W3185221494C142724271 @default.
- W3185221494 hasConceptScore W3185221494C143998085 @default.
- W3185221494 hasConceptScore W3185221494C144301174 @default.
- W3185221494 hasConceptScore W3185221494C146357865 @default.
- W3185221494 hasConceptScore W3185221494C151730666 @default.
- W3185221494 hasConceptScore W3185221494C207103383 @default.
- W3185221494 hasConceptScore W3185221494C2780824555 @default.
- W3185221494 hasConceptScore W3185221494C38180746 @default.
- W3185221494 hasConceptScore W3185221494C44249647 @default.
- W3185221494 hasConceptScore W3185221494C544855455 @default.
- W3185221494 hasConceptScore W3185221494C71924100 @default.
- W3185221494 hasConceptScore W3185221494C86803240 @default.
- W3185221494 hasIssue "3" @default.
- W3185221494 hasLocation W31852214941 @default.
- W3185221494 hasOpenAccess W3185221494 @default.
- W3185221494 hasPrimaryLocation W31852214941 @default.
- W3185221494 hasRelatedWork W2085738063 @default.
- W3185221494 hasRelatedWork W2367054191 @default.
- W3185221494 hasRelatedWork W2367617697 @default.
- W3185221494 hasRelatedWork W2411442805 @default.
- W3185221494 hasRelatedWork W2415741046 @default.
- W3185221494 hasRelatedWork W2772204338 @default.
- W3185221494 hasRelatedWork W2981648456 @default.
- W3185221494 hasRelatedWork W3032086589 @default.
- W3185221494 hasRelatedWork W3140385248 @default.
- W3185221494 hasRelatedWork W4283321516 @default.
- W3185221494 hasVolume "6" @default.
- W3185221494 isParatext "false" @default.
- W3185221494 isRetracted "false" @default.
- W3185221494 magId "3185221494" @default.
- W3185221494 workType "article" @default.